We are live on ! Find out more
ALIM

Alimera Sciences
ALIM

Delisted

ALIM was delisted on the 13th of September, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Alimera Sciences in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 52 → 0 (-52)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $258M → $0 (-$258M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 52

Holders
–
Holders Change
-52
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
52
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CP
Caligan Partners
New York
-$93.6M
2
VCIM
Velan Capital Investment Management
Georgia
-$75.7M
3
SCM
Stonepine Capital Management
Oregon
-$19.5M
4
BFM
Boothbay Fund Management
New York
-$17.8M
5
ACM
Altium Capital Management
New York
-$12M
Name Holding Trade Value Shares
Change 		Change in
Stake
CP
1
Caligan Partners
New York
– -$93.6M -16,835,154 Closed
VCIM
2
Velan Capital Investment Management
Georgia
– -$75.7M -13,608,533 Closed
SCM
3
Stonepine Capital Management
Oregon
– -$19.5M -3,511,816 Closed
BFM
4
Boothbay Fund Management
New York
– -$17.8M -3,198,708 Closed
ACM
5
Altium Capital Management
New York
– -$12M -2,150,000 Closed
BlackRock
6
BlackRock
New York
– -$7.7M -1,385,434 Closed
Vanguard Group
7
Vanguard Group
Pennsylvania
– -$6.55M -1,177,745 Closed
JP Morgan Chase
8
JP Morgan Chase
New York
– -$5.58M -1,003,617 Closed
Geode Capital Management
9
Geode Capital Management
Massachusetts
– -$3.55M -638,396 Closed
GCL
10
Glazer Capital LLC
New York
– -$3.07M -551,533 Closed
Morgan Stanley
11
Morgan Stanley
New York
– -$2.87M -515,304 Closed
State Street
12
State Street
Massachusetts
– -$2.08M -374,531 Closed
Renaissance Technologies
13
Renaissance Technologies
New York
– -$1.01M -181,694 Closed
BCM
14
Bridgeway Capital Management
Texas
– -$773K -139,100 Closed
DAM
15
Deltec Asset Management
New York
– -$690K -124,169 Closed
GF
16
Gabelli Funds
New York
– -$600K -108,000 Closed
Qube Research & Technologies (QRT)
17
Qube Research & Technologies (QRT)
United Kingdom
– -$543K -97,741 Closed
Northern Trust
18
Northern Trust
Illinois
– -$480K -86,299 Closed
VF
19
Virtu Financial
New York
– -$346K -62,284 Closed
Bank of New York Mellon
20
Bank of New York Mellon
New York
– -$344K -61,907 Closed
GCIA
21
Gabelli & Co Investment Advisers
New York
– -$337K -60,650 Closed
RC
22
RBF Capital
California
– -$334K -60,000 Closed
Charles Schwab
23
Charles Schwab
California
– -$280K -50,431 Closed
GS
24
GTS Securities
New York
– -$222K -40,000 Closed
PCM
25
PenderFund Capital Management
British Columbia, Canada
– -$299K -39,300 Closed
1
2 3

ALIM Hedge Fund Activity: Q3 2024 in Review

0 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q3 2024, worth a combined $0 — down 100% from $258M a quarter earlier.

Sellers outnumbered buyers: 52 funds closed out of ALIM and 0 opened new positions — a net loss of 52 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Caligan Partners, exiting entirely with an estimated $93.6M sold.

  • 0 institutional investors held Alimera Sciences (ALIM) as of Q3 2024, down from 52 in Q2 2024.
  • Funds reported $0 of Alimera Sciences stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Alimera Sciences positions in Q3 2024 and 52 closed out, a net change of -52 holders.
  • The largest Alimera Sciences seller in Q3 2024 was Caligan Partners, an estimated $93.6M sold.

Based on aggregated 13F filings for Q3 2024.